These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Tobacco cessation pharmacotherapy use among First Nations persons residing within British Columbia. Wardman AE; Khan N Nicotine Tob Res; 2004 Aug; 6(4):689-92. PubMed ID: 15370165 [TBL] [Abstract][Full Text] [Related]
15. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223 [TBL] [Abstract][Full Text] [Related]
16. Nicotine and non-nicotine smoking cessation pharmacotherapies. Frishman WH; Mitta W; Kupersmith A; Ky T Cardiol Rev; 2006; 14(2):57-73. PubMed ID: 16493243 [TBL] [Abstract][Full Text] [Related]
17. A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas. Hill A Tex Med; 2006 Aug; 102(8):50-5. PubMed ID: 17115560 [No Abstract] [Full Text] [Related]
18. The use of the nicotine inhaler in smoking cessation. Burkett JS J Am Acad Nurse Pract; 2006 Mar; 18(3):83-91. PubMed ID: 16499741 [TBL] [Abstract][Full Text] [Related]
19. Bupropion for the treatment of nicotine withdrawal and craving. Mooney ME; Sofuoglu M Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112 [TBL] [Abstract][Full Text] [Related]